Business Wire

SORIN-GROUP

Del
Sorin Group Announces Global Launch of Its Latest Generation of Heating and Cooling Systems at FECECT 2015

Sorin Group (MIL:SRN), (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced the launch of its latest generation of heating and cooling systems, FlexTherm, at FECECT 2015, the 16th European Congress on Extracorporeal Circulation Technology.

During open-heart surgery procedures requiring cardiopulmonary bypass, the heating and cooling system is used to control and manage the patient’s body temperature by cooling and re-warming blood during the different phases of surgery, through the oxygenator system, and to cool the cardioplegia solution delivered to achieve the patient’s myocardial protection.

Different re-warming strategies have been associated with postoperative neurocognitive function in adult patients undergoing coronary artery bypass graft surgery. Precise temperature control during cardiopulmonary bypass procedures may contribute to decrease morbidity after coronary revascularization and to lower the risk of postoperative impairment of the neurocognitive function, thus improving patient outcome. 1

A simple, display-guided disinfection procedure, which includes a reminder function, reduces operator time and provides maximum protection against bacteria. The new process takes only 35 minutes operator time once every 14 days. The safe and effective, display-guided procedure eliminates the risk for errors. Streamlining the disinfection process maximizes safety for the patients against infections and reduces the time dedicated to disinfection, helping decrease the overall cost of care for hospitals.

“FlexTherm guided disinfection procedure is a huge improvement versus the previous generation 3T heater-cooler system: it is easier and faster for clinicians. It saves operator’s time, reduces hospital costs and resource utilization and, even more important, it minimizes the risk of errors and provides reminders on how to conduct disinfection for the safety of our patients,” said Dr. Dirk Buchwald, Chief of Cardiovascular Perfusion at Bergmannsheil University Hospital in Bochum, Germany, after using FlexTherm for the first time.

FlexTherm is equipped with three water tanks, each with a different temperature setting, allocated to three independent water circuits. This design enables superior temperature control and maximum flexibility for use in various simultaneous applications. Precise water flow measurement ensures efficacy and increased control in energy transfer when heating and cooling the patient.

FlexTherm is the latest addition to the Sorin HeartLink System, the first automatically integrated perfusion management system designed for improved patient outcomes, increased clinical efficacy and Goal-

Directed Perfusion, built on the world-leading Sorin S5 perfusion system. It links to the Sorin Connect data management system, which automatically collects, monitors, and records the heating and cooling process during the intervention for complete traceability and data management.

In 2014 the production area at Sorin Group Deutschland in Munich was increased by 20% to manufacture FlexTherm completely in house. Munich is Sorin Group’s center of excellence for manufacturing cardiac surgery equipment such as the S5 and the C5 heart-lung-machines, the Xtra autotransfusion machine and the Connect data management system. This allows Sorin Group total control over the manufacturing processes, enhancing the strategic know-how and leadership in the heart-lung machines segment.

“FlexTherm is a very nice complement to the S5 family,” said Roel Hendrickx, perfusionist at Catharina Hospital, Eindhoven, The Netherlands, who controlled remotely the FlexTherm system located outside the operating room, from the S5 heart-lung machine.

“Another significant improvement in FlexTherm is its S5-like user interface. The user interface is similar to the S5 displays; it is therefore intuitive and easy to understand. In addition, FlexTherm is very silent, even when cooling”, said Krzysztof Klak, perfusionist at the Bergmannsheil University Hospital, Bochum, Germany.

“We are proud to introduce FlexTherm as the newest cardiac surgery solution that Sorin Group offers to hospitals worldwide,” said Michel Darnaud, President, Cardiac Surgery Business Unit, Sorin Group, ” FlexTherm is the latest addition to Sorin HeartLink TM System, the unique automatically integrated perfusion management system designed for improved patient outcomes, increased clinical efficacy and Goal-Directed Perfusion” .

1. B Bikash Sahu et Al. Neurocognitive Function in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass: The Effect of Two Different Rewarming Strategies. Journal of Cardiothoracic and Vascular Anesthesia. Published Online: September 25, 2008.

About Sorin Group
Sorin Group (www.sorin.com ) is a global, medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,900 employees worldwide,Sorin Group focuses on two major therapeutic areas: Cardiac Surgery (cardiopulmonary products for open heart surgery and heart valve repair or replacement prostheses) and Cardiac Rhythm Management (pacemakers, defibrillators and non invasive monitoring to diagnose arrhythmias and deliver anti-arrhythmia therapies as well as cardiac resynchronization devices for heart failure treatment) Every year, over one million patients are treated with Sorin Group devices in more than 100 countries.

For more information, please visit www.sorin.com

Contact:

Gabriele Mazzoletti, Tel: +39 02 69969785
Mobile: +39 348 9792201
Director, Corporate Communications
Sorin Group
e-mail: corporate.communications@sorin.com
or
Francesca Rambaudi, Tel: +39 02 69969716
Director, Investor Relations
Sorin Group
E-mail: investor.relations@sorin.com

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM31.8.2025 11:15:00 CEST | Press release

− Sustained Benefit of Vutrisiran Across Mortality, Cardiovascular Events, Quality of Life and Cardiac Biomarkers Observed Through Up to 48 Months, Including 12 Months from the Ongoing Open-Label Extension, Reinforce Potential as First-Line Treatment for ATTR-CM –− Vutrisiran, which Delivers Rapid Knockdown of Transthyretin, Reduced the Risk of Composite of All-Cause Mortality or First Cardiovascular Event by 37% in the Overall Population and 42% in the Monotherapy Group During the Same Period – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results of new analyses from the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic approved for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. Data from the 12-month follow-up of the ongoing open-label extension (OLE) period of HELIOS-B were presented during an oral session at the European Society of Card

WETEX Opens Broad Investment Horizons for International Companies31.8.2025 08:30:00 CEST | Press release

DEWA will organise the exhibition from 30 September to 2 October 2025 Under the directives of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, and the patronage of HH Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Supreme Council of Energy, Dubai Electricity and Water Authority (DEWA) will organise the 27th edition of the Water, Energy, Technology and Environment Exhibition (WETEX) from 30 September to 2 October 2025 at the Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250830023664/en/ WETEX opens broad investment horizons for international companies (Photo: AETOSWire) WETEX embodies the UAE's pioneering position in clean and renewable energy and sustainability. It also supports Dubai's ambitious vision of a sustainable economy. The exhibition covers multiple areas including water, energy, smart cities, green mobility, artificial i

Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C30.8.2025 18:00:00 CEST | Press release

Initiation of the development of new oral triple combination tablets, aimed at improving adherence and outcomes in low-density lipoprotein cholesterol (LDL-C) management. Recent findings from MILOS and SANTORINI registries presented at ESC Congress 2025, highlight ongoing challenges in accurately assessing cardiovascular (CV) risk and helping patients reach LDL-C targets.1-5 Furthermore, data from a four-country cohort of the MILOS study support the real-world effectiveness and safety of bempedoic acid in both sexes.6 Simulation using SANTORINI data reveals the potential of improved LDL-C goal attainment with tailored oral combination therapy of statins, ezetimibe and bempedoic acid, in line with the latest 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.7,8 Daiichi Sankyo has a long-standing commitment to easing treatment of cardiovascular disease (CVD) and exploring new treatment options that improve CVD outcomes and treatment adherence. Daiich

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial30.8.2025 16:30:00 CEST | Press release

- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society of Cardiology Congress 2025 -- Zilebesiran Demonstrated Clinically Meaningful Reductions in Office Systolic Blood Pressure in Patients with Uncontrolled Hypertension and High Cardiovascular Risk at Month 3 Primary Endpoint, with Continuous Control Through Month 6 -- Zilebesiran Displayed Encouraging Safety When Combined with Two or More Antihypertensives -- Results Support Biannual Dosing Regimen and Inform Phase 3 Trial Design: Trial Expected to Initiate by Year-End 2025 -- Alnylam to Host Webcast Investor Event on August 30, 2025, at 1:00 pm ET (7:00 pm CEST) - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced plans to initiate a Phase 3 cardiovascular outcomes trial (CVOT) to evaluate the potential of zilebesiran to reduce the risk of major adverse cardiovascular events. This decision is informed by results from t

Andersen Consulting styrker sine kompetencer inden for virksomhedstransformation med Fabric29.8.2025 17:01:00 CEST | Pressemeddelelse

Andersen Consulting udvider sin platform gennem en samarbejdsaftale med Fabric, der er et strategisk designfirma, der arbejder med organisationer for at integrere bæredygtighed, forsyningskæder og menneske-centreret innovation på tværs af kultur og drift. Fabric blev grundlagt i Japan i 2021 og arbejder sammen med virksomheder og globale brands om at skabe regenerative forretningsmodeller sammen samt bæredygtige brandstrategier og fremtidssikrede produkter. Ved hjælp af strategiske designmetoder og designfilosofi skaber virksomheden indsigtsbaseret transformation på tværs af forsyningskæder, brand og HR. Fabric er kendt for sin systemtænkning og sit engagement i social og miljømæssig bæredygtighed og fremmer desuden digitale transformationsinitiativer, der integrerer bæredygtighed, humankapital og AI. "Fabric er skabt for at hjælpe virksomheder med at blomstre gennem regenerative relationer til mennesker, samfund og forbundne, levende systemer," sagde James Hollow, der er grundlægger a

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye